Calif. Drug Ruling Affirms Defect-Centric Liability Framework
By Mara Cusker Gonzalez, Mary Kim and Christopher McKeon · August 5, 2026, 4:43 PM EDT
In a long-awaited decision in Gilead Tenofovir Cases, the California Supreme Court held this week that drug manufacturers do not owe a duty of care to users of a nondefective drug...
To view the full article, register now.